Framingham, MA, United States of America

Alzheon, Inc.


USPTO Granted Patents = 9


Forward Citations = 10

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Petr Kocis (9 out of 9 patents)

silverMedal Martin Tolar (9 out of 9 patents)

bronzeMedal John A Hey (9 out of 14 patents)

4.  Jeremy Yu (2 out of 2 patents)

5.  Susan Abushakra (1 out of 1 patent)

6.  Aidan Power (1 out of 1 patent)

7.  Neil William Flanzraich (1 out of 1 patent)


9 patents:

Company Overview
Alzheon, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative medicines for patients suffering from neurodegenerative diseases, including Alzheimer's disease. The company's lead product candidate, ALZ-801, is in development as a potential treatment for early and mild Alzheimer's disease. Alzheon's mission is to deliver new treatment options that target the underlying pathology of neurodegenerative diseases to improve the lives of patients and their families.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#28 in Framingham, MA

#1,926 in Massachusetts

#32,588 in US

Framingham, MA (US)
Framingham, MA, United States of America
Forward Citations = 10

7 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alzheon, Inc.. Retrieved from https://idiyas.com/company/alzheon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…